MYCO-002

MYCO-002
Clinical data
Other namesMYCO002
Drug classEntactogen; Empathogen

MYCO-002 is an MDMA-like entactogen that is under development for the treatment of psychiatric disorders.[1][2][3] It is said to be being developed towards the aim of improving the safety profile of MDMA.[3] The drug is under development by Mydecine.[1][2] It was patented in July 2021 and received breakthrough therapy designation from the Food and Drug Administration (FDA) in November 2021.[1] As of November 2021, MYCO-002 is in the preclinical research for treatment of psychiatric disorders.[1][2] The chemical structure of MYCO-002 does not yet appear to have been disclosed.[1][2]

See also

References

  1. ^ a b c d e "MYCO 002". AdisInsight. 28 November 2021. Retrieved 29 January 2025. MYCO 002 is an entactogenic MDMA-like compound being developed by Mydecine Innovations for the potential treatment of mental disorders. [...]
  2. ^ a b c d "Delving into the Latest Updates on MYCO-002 with Synapse". Synapse. 23 January 2025. Retrieved 29 January 2025.
  3. ^ a b Mydecine Innovations Group (7 April 2021). "Mydecine Announces Four Lead Novel Drug Candidates and Prepares for Pre-IND Meetings with the FDA and Health Canada To Prepare For Human Clinical". GlobeNewswire News Room. Retrieved 29 January 2025. The four initial drug candidates include: [...] MYCO - 002 is an entactogenic compound that has been created with the goal of reducing harm and improving the safety profile vs. traditional MDMA.



Stub icon

This psychoactive drug-related article is a stub. You can help Wikipedia by adding missing information.

Content Disclaimer

Informasi ini disarikan dari Wikipedia dan disajikan kembali untuk tujuan edukasi. Konten tersedia di bawah lisensi CC BY-SA 3.0. Kami tidak bertanggung jawab atas ketidakakuratan data yang bersumber dari kontribusi publik tersebut.

  1. The information displayed on this website is sourced in part or in whole from Wikipedia and has been adapted for the purpose of restating it. We strive to provide accurate and relevant information, however:
  2. There is no guarantee of absolute accuracy. Wikipedia is an open, collaborative project that can be edited by anyone, so information is subject to change.
  3. It is not intended to constitute professional advice. The content displayed is for informational and educational purposes only. For important decisions (e.g., medical, legal, or financial), please consult a professional.
  4. Content copyright. Wikipedia is licensed under the Creative Commons Attribution-ShareAlike License (CC BY-SA). This means that content may be reused with appropriate attribution and shared under a similar license.
  5. Responsible use. Any risk arising from the use of information from this website is entirely the responsibility of the user.